Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-907-6 | CAS number: 84775-78-0 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Ascophyllum nodosum, Fucaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June-October 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: in accordance with guidelines
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Ascophyllum nodosum, ext.
- EC Number:
- 283-907-6
- EC Name:
- Ascophyllum nodosum, ext.
- Cas Number:
- 84775-78-0
- Molecular formula:
- Not applicable; a generic molecular formula cannot be provided for this UVCB substance.
- IUPAC Name:
- Ascophillum nodosum, extract
- Details on test material:
- - Name of test material (as cited in study report): Algea Fert Solid K+
- Substance type: fertilizer ( algal extract)
- Physical state: solid, black micro-flakes
- Lot/batch No.: 00680
- Expiration date of the lot/batch: March 2012
- Stability under test conditions: Stable under suitable storage conditions.
- Storage condition of test material: original tightly-closed containers in well- ventilated place.
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Oxide nutrient broth No. 2. Minimal glucose agar contained agar, Vogel-Bonner minimal medium E and 40% glucose. The overlay agar contained 0.6% agar, 0.5% NaCl and 0.05 mM histidine - biotin (Maron and Ames, 1983).
- Properly maintained: yes
- Species / strain / cell type:
- S. typhimurium TA 97
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Oxide nutrient broth No. 2. Minimal glucose agar contained agar, Vogel-Bonner minimal medium E and 40% glucose. The overlay agar contained 0.6% agar, 0.5% NaCl and 0.05 mM histidine - biotin (Maron and Ames, 1983).
- Properly maintained: yes
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Oxide nutrient broth No. 2. Minimal glucose agar contained agar, Vogel-Bonner minimal medium E and 40% glucose. The overlay agar contained 0.6% agar, 0.5% NaCl and 0.05 mM histidine - biotin (Maron and Ames, 1983).
- Properly maintained: yes
- Species / strain / cell type:
- S. typhimurium TA 100
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Oxide nutrient broth No. 2. Minimal glucose agar contained agar, Vogel-Bonner minimal medium E and 40% glucose. The overlay agar contained 0.6% agar, 0.5% NaCl and 0.05 mM histidine - biotin (Maron and Ames, 1983).
- Properly maintained: yes
- Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Oxide nutrient broth No. 2. Minimal glucose agar contained agar, Vogel-Bonner minimal medium E and 40% glucose. The overlay agar contained 0.6% agar, 0.5% NaCl and 0.05 mM histidine - biotin (Maron and Ames, 1983).
- Properly maintained: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mammalian liver fraction
- Test concentrations with justification for top dose:
- 5000 µg, 1500 µg, 500 µg, 150 µg and 50 µg/plate, both with and without metabolic activation system (S9)
Test concentrations for this study were selected from the results obtained with solubility/ precipitation test and preliminary cytotoxicity test of the test article employing only TA100, with and without the metabolic activation system.
ALGEA FERT SOLID K+ was found completely soluble in Analytical grade water at a concentration of 50 mg/ml. No precipitation was observed in the final reaction mixture up to the concentrations of 1.85 mg/ml, corresponding to final test concentrations of 5000 µg/plate. 5000 µg/plate was the highest concentration selected for the preliminary cytotoxicity study.
Before commencing the study, the test article was assessed for cytotoxicity to the tester bacteria using tester strain TA100. Five concentrations viz. 5000 µg, 1500 µg, 500 µg, 150 µg, and 50µg/plate of the test article, suspended in analytical grade water, were tested for toxicity to bacterial cells.
ALGEA FERT SOLID K+ was not found to be cytotoxic to the bacterial cells at the maximum concentration of 5000 µg/plate. Hence 5000 µg/plate was selected as the maximum test concentration for main study. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water, analytical grade
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- 2 µg/plate, without S9 mix
Migrated to IUCLID6: for TA1535
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ICR 191, for TA97a
- Remarks:
- 1 µg/plate, without S9 mix
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- 0.5 µg/plate, without S9 mix
Migrated to IUCLID6: for TA98
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 3-Methylmethane sulphonate, for TA100 and TA102
- Remarks:
- 1 µg/plate, without S9 mix
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene, for TA1535
- Remarks:
- 10 µg/plate, with S9 mix
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- 20 µg/plate, with S9 mix
Migrated to IUCLID6: for TA97a, TA98 and TA100
- Untreated negative controls:
- yes
- Remarks:
- overlay agar supplemented with histidine, served as a control to check spontaneous revertants.
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Danthron, for TA102
- Remarks:
- 30 µg/plate, with S9 mix
- Details on test system and experimental conditions:
- All the tester strains are defective in DNA repair capacity (uvrB), except TA102 and all tester strains have a defective lipopolysaccharide barrier on the cell wall (rfa). These two properties confer extra sensitivity to DNA damage and also increase permeability to large molecules that do not penetrate the normal cell wall.
Strains TA97a, TA98, TA100 and TA102 also contain resistance transfer factor (plasmid pKM 101). This factor, which confers resistance to ampicillin, enhances the operation of an error prone repair system.
In case of TA102, it contains plasmid pAQ1, which confers resistance to tetracycline.
Strains TA1535 and TA100 are highly sensitive to base - pair substitution mutation and TA97a, TA98 are highly sensitive to frame - shift mutation.
The strain TA102 contains ochre mutation.
The strains are tested routinely for other genotypic characters such as:
- Histidine requirement – The His - character of all tester strains was confirmed by demonstrating the histidine requirement for growth on selective agar plates.
- rfa mutation, i.e. cell membrane permeability was checked through sensitivity to crystal violet;
- uvrB mutation was checked through sensitivity to ultra-violet light (TA1535, TA98, TA100 and TA97a);
- R- factor plasmid (pKM101) - Presence or absence of R- factor plasmid was checked through ampicillin resistance (TA98, TA100 and TA97a), and
- pAQ1 plasmid - The pAQ1 strain (TA102) was tested for both ampicillin and tetracycline resistance (TA102).
Frozen permanent copies of the tester strains were stored in liquid nitrogen cylinders (cryocan) at about -196°C. They were prepared from fresh overnight culture to which DMSO was added as a cryoprotective agent.
In addition to frozen permanents, the tester strains were routinely maintained in the laboratory on master plates, which were stored at 2-8°C.
Master plates were used as the source of bacteria for inoculating the overnight culture for frequently used strains.
Maximum dose of 5000 µg/plate, which was not found to be cytotoxic to TA100 in the preliminary cytotoxicity, was selected as the highest dose level, with four lower dose levels viz. 1500 µg, 500 µg, 150 µg and 50 µg/plate being selected for the main assay. Triplicate plating was performed at each dose level for an adequate evaluation of the variation.
Pre-Incubation Assay without Metabolic Activation:
Aliquots of 0.1 ml cell suspension of the tester strains, containing about 108 viable cells, were added to sets of sterile tubes. Sterile phosphate buffer (0.5 ml) and freshly prepared test product / control sample / positive control (0.1 ml) were added to the tube. All the constituents of reaction mixture were introduced into sterile test tubes on an ice bath. The tubes with reaction mixture were mixed by shaking gently and were incubated at 37 ± 1 °C for 20-30 minutes in laboratory incubator.
Finally 2 ml of overlay agar with histidine-biotin, previously melted and cooled to about 45 °C, was added. The contents will be mixed and poured over the surface of the petri plates containing minimal glucose VB agar. The overlay agar will be allowed to solidify before incubation.
Pre-Incubation Assay with Metabolic Activation:
Aliquots of 0.1 ml cell suspension of the tester strains, containing about 108 viable cells, were added to sets of sterile tubes. The S9 mixture (0.5 ml) and freshly prepared test product / control sample / positive control (0.1 ml) were added to the tube. All the constituents of reaction mixture were introduced into sterile test tubes on an ice bath. The tubes with reaction mixture were mixed by shaking gently and were incubated at 37 ± 1 °C for 20-30 minutes in laboratory incubator.
Finally 2 ml of overlay agar with histidine-biotin, previously melted and cooled to about 45°C, was added. The contents were mixed and poured over the surface of the petri plates containing minimal glucose VB agar. The overlay agar was allowed to solidify before incubation.
INCUBATION: Contents of all the plates were allowed to solidify after which the plates were inverted and incubated at 37±1°C for 48-72 hours.
Test for Sterility:
To ensure sterility of the vehicle, tests for evaluation of contamination were performed along with the assay. The solvent, overlay agar, S9 mix and the highest employed dose of the test article were evaluated at the same volume that was used in the assay, but in the absence of tester bacteria. Overlay agar alone was also plated on minimal glucose VB agar. Plates for laminar flow were exposed to the laminar flow during treatment. All plating was done in triplicate. Plates were incubated for 48-72 hours at 37±1°C and then assessed for presence of contamination if any, in the form of growth of colonies on the agar. - Evaluation criteria:
- A test article is considered as mutagenic if it produces a concentration related increase over the range tested and /or a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation system.
The biologically significant increase would be assumed if the average colony counts are: at least twice as compared to those in vehicle control group for strain TA97a, TA98, TA100 and TA102 and at least thrice as compared to those in vehicle control group for strain TA1535.
A test article is considered as non-mutagenic, if it does not induce any increase in the number of revertants and does not show any dose response relationship, in two separate experiments, with any bacterial strain, either with or without metabolic activation.
OBSERVATION: After incubation period, the plates were checked for sterility. The plates were observed for a uniform lawn of auxotrophs (his-) and the colonies for histidine revertants as the prototrophs (his+). Histidine revertant colonies per plate were counted and the mean number of colonies at each test point was calculated.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- REVERTANT FREQUENCIES IN VEHICLE CONTROL GROUPS
Plate counts for the spontaneous histidine revertant colonies in the vehicle control groups were found to be within the frequency ranges expected from the laboratory historical control data at INTOX. They also compared well with the range reported in the published literature.
REVERTANT FREQUENCIES IN TREATMENT GROUPS
Frequencies of histidine revertant colonies observed at all concentrations of ALGEA FERT SOLID K+ in tester strains TA1535, TA97a and TA100, with and without the presence of a metabolic activation system, were comparable to those observed in the vehicle control groups, as per the criteria employed for evaluation of mutagenic potential.
In first experiment histidine revertant colonies of tester strains TA 98 at 1500 µg/plate in absence of S9 metabolic activation, were increased, while the same was not observed in second experiment. Thus, this increase was not found to be reproducible.
ALGEA FERT SOLID K+ was found to be slightly cytotoxic to strain TA102 at 5000µg/plate with metabolic activation. While frequencies of histidine revertant colonies observed for remaining concentrations of ALGEA FERT SOLID K+ in tester strains TA102 with and without the presence of a metabolic activation system, were comparable to those observed in the vehicle control groups, as per the criteria employed for evaluation of mutagenic potential.
These observations were confirmed by repetition of the experiments.
REVERTANT FREQUENCIES IN POSITIVE CONTROL GROUPS
Concurrent positive controls demonstrated sensitivity of the assay with and without metabolic activation. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
TESTS FOR Genetic Traits
Sr. No. |
Character
|
Results |
|||||
TA97a |
TA98 |
TA100 |
TA102 |
TA1535 |
|||
1 |
Histidine requirement |
Desired |
P |
P |
P |
P |
P |
Observed |
P |
P |
P |
P |
P |
||
2 |
rfa mutation |
Desired |
P |
P |
P |
P |
P |
Observed |
P |
P |
P |
P |
P |
||
3 |
Defective DNA repair system (DuvrB) |
Desired |
P |
P |
P |
A |
P |
Observed |
P |
P |
P |
A |
P |
||
4 |
R- factor |
Desired |
P |
P |
P |
P |
A |
Observed |
P |
P |
P |
P |
A |
||
5 |
pAQ1 Plasmid |
Desired |
A |
A |
A |
P |
A |
Observed |
A |
A |
A |
P |
A |
P - Character should be / found to be present ; A - Character should be / found to be absent
Desired – desired status for the respective strain and the character.
Observed – observed status for the character as observed when tested.
FREQUENCIES OF Spontaneous HISTIDINE REVERTANTS
Tester Strain |
Plate Counts of Spontaneous Histidine Revertants Colonies |
||||
Replicate 1 |
Replicate 2 |
Replicate 3 |
Mean |
+SD |
|
TA97a |
150 |
188 |
144 |
160.67 |
23.86 |
TA 98 |
18 |
30 |
17 |
21.67 |
7.23 |
TA 100 |
142 |
165 |
143 |
150.00 |
13.00 |
TA 102 |
287 |
280 |
279 |
282.00 |
4.36 |
TA 1535 |
5 |
9 |
12 |
8.67 |
3.51 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Salmonella typhimurium, Reverse Mutation Assay of ALGEA FERT SOLID K+ was carried out in compliance with the OECD Guidelines for Testing of Chemicals (No. 471, Section 4: Health Effects) on conduct of "Bacterial Reverse Mutation Test", adopted 21 July 1997.
Under the conditions described for this study, it is concluded that, ALGEA FERT SOLID K+ is non-mutagenic in Salmonella typhimurium strains TA1535, TA97a, TA98, TA100 and TA102. - Executive summary:
Salmonella typhimurium,Reverse Mutation Assay of ALGEA FERT SOLID K+ was carried out in compliance with the OECD Guidelines for Testing of Chemicals (No. 471, Section 4: Health Effects) on conduct of "Bacterial Reverse Mutation Test", adopted 21 July 1997 and as per mutually agreed protocol.
ALGEA FERT SOLID K+ was evaluated in the/ Salmonella Pre-incubation Assay to determine its ability to induce reverse mutation at selected histidine loci in five tester strains of Salmonella typhimuriumviz. TA1535, TA97a, TA98, TA100 and TA102 in the presence and absence of metabolic activation system (S9). Based upon the preliminary tests conducted to assess the solubility / precipitation and cytotoxicity of ALGEA FERT SOLID K+, the tester strains were exposed to the test article in triplicate cultures at the doses of 5000 µg, 1500 µg, 500 µg, 150 µg and 50 µg/plate, both with and without metabolic activation system (S9). Liver S9, induced in Sprague Dawley rats by phenobarbitone withb- naphthoflavone, was used for this purpose.
Analytical grade water was used as a vehicle. The exposed bacteria were plated onto minimal glucose agar medium supplemented with L-histidine. The plates were incubated at 37+1°Cfor 48-72 hours after which the histidine revertant colonies were counted and their frequency was compared with that in the vehicle control group. Concurrent positive control groups were also included in the experiment, as specified by the test guideline. Results of this test indicated that the frequencies of histidine revertant colonies at all concentrations ofALGEA FERT SOLID K+instrains TA1535, TA97a, TA98, TA100 and TA102, with and without the presence of a metabolic activation system, were comparable to those observed in the vehicle control group, as per the criteria employed for evaluation of mutagenic potential, and this observation was confirmed by repetition of the experiments. Plate counts for the spontaneous histidine revertant colonies in the vehicle control groups were found to be within the frequency ranges expected from the laboratory historical control data at INTOX. They also compared well with the range reported in the literature. Concurrent positive controls demonstrated sensitivity of the assay with and without metabolic activation. It is concluded that, under the conditions of this study, ALGEA FERT SOLID K+ is non-mutagenic in Salmonella typhimurium strains TA1535, TA97a, TA98, TA100 and TA102.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.